Mid-infrared plasmonic inductors: Enhancing inductance with meandering lines

UPNa. Departamento de Ingeniería Eléctrica y Electrónica. Laboratorio de fotónica TERALABWe present a mid-infrared inductor that when applied to an extraordinary transmission hole array produces a strong redshift of the resonant peak accompanied by an unprecedented enlargement of the operation bandwidth. The importance of the result is twofold: from a fundamental viewpoint, the direct applicability of equivalent circuit concepts borrowed from microwaves is demonstrated, in frequencies as high as 17â€...THz upholding unification of plasmonics and microwave concepts and allowing for a simplification of structure design and analysis; in practical terms, a broadband funnelling ofinfrared radiation with fractional bandwidth and efficiency as high as 97% and 48%, respectively, is achieved through an area less than one hundredth the squared wavelength, which leads to an impressive accessible strong field localization that may be of great interest in sensing applications.Effort sponsored by Spanish Government under contracts Consolider EngineeringMetamaterials CSD2008-00066, TEC2011-28664-C01 and TEC2011-28664-C02. V.T. acknowledges funding from Universidad Pública de Navarra. P.R.-U. is sponsored by the Government of Navarra under funding program Formación de tecnólogos 055/01/11. M.N.-C. is supported by the Imperial College Junior Research Fellowship. M.B. acknowledges funding by the Spanish Government under the research contract program Ramón y Cajal RYC-2011-08221

Choline transporter gene variation is associated with attention-deficit hyperactivity disorder

The neurotransmitter acetylcholine (ACh) plays a critical role in brain circuits mediating motor control, attention, learning and memory. Cholinergic dysfunction is associated with multiple brain disorders including Alzheimer’s Disease, addiction, schizophrenia and Attention-Deficit Hyperactivity Disorder (ADHD). The presynaptic choline transporter (CHT, SLC5A7) is the major, rate-limiting determinant of ACh production in the brain and periphery and is consequently upregulated during tasks that require sustained attention. Given the contribution of central cholinergic circuits to the control of movement and attention, we hypothesized that functional CHT gene variants might impact risk for ADHD. We performed a case-control study, followed by family-based association tests on a separate cohort, of two purportedly functional CHT polymorphisms (coding variant Ile89Val (rs1013940) and a genomic SNP 3’ of the CHT gene (rs333229), affording both a replication sample and opportunities to reduce potential population stratification biases. Initial genotyping of pediatric ADHD subjects for two purportedly functional CHT alleles revealed a 2–3 fold elevation of the Val89 allele (n = 100; P = 0.02) relative to healthy controls, as well as a significant decrease of the 3’SNP minor allele in Caucasian male subjects (n = 60; P = 0.004). In family based association tests, we found significant overtransmission of the Val89 variant to children with a Combined subtype diagnosis (OR = 3.16; P = 0.01), with an increased Odds Ratio for a haplotype comprising both minor alleles. These studies show evidence of cholinergic deficits in ADHD, particularly for subjects with the Combined subtype, and, if replicated, may encourage further consideration of cholinergic agonist therapy in the disorder

New insights into the synergism of nucleoside analogs with radiotherapy

Nucleoside analogs have been frequently used in combination with radiotherapy in the clinical setting, as it has long been understood that inhibition of DNA repair pathways is an important means by which many nucleoside analogs synergize. Recent advances in our understanding of the structure and function of deoxycytidine kinase (dCK), a critical enzyme required for the anti-tumor activity for many nucleoside analogs, have clarified the mechanistic role this kinase plays in chemo- and radio-sensitization. A heretofore unrecognized role of dCK in the DNA damage response and cell cycle machinery has helped explain the synergistic effect of these agents with radiotherapy. Since most currently employed nucleoside analogs are primarily activated by dCK, these findings lend fresh impetus to efforts focused on profiling and modulating dCK expression and activity in tumors. In this review we will briefly review the pharmacology and biochemistry of the major nucleoside analogs in clinical use that are activated by dCK. This will be followed by discussions of recent advances in our understanding of dCK activation via post-translational modifications in response to radiation and current strategies aimed at enhancing this activity in cancer cells

Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics

The assessment of oocyte quality in human in vitro fertilization (IVF) is getting increasing attention from embryologists. Oocyte selection and the identification of the best oocytes, in fact, would help to limit embryo overproduction and to improve the results of oocyte cryostorage programs. Follicular fluid (FF) is easily available during oocyte pick-up and theorically represents an optimal source on non-invasive biochemical predictors of oocyte quality. Unfortunately, however, the studies aiming to find a good molecular predictor of oocyte quality in FF were not able to identify substances that could be used as reliable markers of oocyte competence to fertilization, embryo development and pregnancy. In the last years, a well definite trend toward passing from the research of single molecular markers to more complex techniques that study all metabolites of FF has been observed. The metabolomic approach is a powerful tool to study biochemical predictors of oocyte quality in FF, but its application in this area is still at the beginning. This review provides an overview of the current knowledge about the biochemical predictors of oocyte quality in FF, describing both the results coming from studies on single biochemical markers and those deriving from the most recent studies of metabolomic

Terahertz modulation using a bandpass filter combined with a graphene supercapacitor

Graphene is proving to be an efficient medium for the control of mm-wave/THz radiation. Its electrical and dielectric properties allows it to be incorporated into various existing device architectures. One such application is in the modulation of the amplitude of the propagating THz radiation. Due to its electrical properties this interaction is typically broadband in nature. To make this frequency selective we propose the use of metamaterials or frequency selective surfaces. Generally, these structures perform the frequency filtering by modifying the propagation of the input wave with respect to changing structural parameters of the device itself. By fabricating a frequency selective surface based on a periodic circular hole array on an aluminum sheet we show that the transmission of a narrow band of THz radiation can be modulated when the sheet is combined with a highly efficient graphene based supercapacitor device. The modulation depth of the device was 15% in the frequency region of interest. The simple structure of the device coupled with the obtained performance shows that graphene based devices have great potential for the development of THz technologies